HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Metabotropic glutamate antagonist, MCPG, treatment of traumatic brain injury in rats.

Abstract
The metabotropic glutamate receptor (mGluR) antagonist, alpha-methyl-4-carboxyphenylglycine (MCPG) was administered into the left lateral ventricle 5 min prior to fluid percussion traumatic brain injury (TBI) in the rat. A single 5.0 microliters ventricular infusion of the active isomer. (+)-MCPG (0.2 mumol), significantly reduced beam walking motor deficits on days 1-5 after injury and learning/memory deficits measured on days 11-15 after injury. Neither a lower dose of (+)-MCPG (0.2 mumol) affected behavioral outcome. (+)-MCPG (0.2 mumol) did not affect systemic hemodynamic responses to injury. These results suggest that TBI induced activation of mGluRs contributes to behavioral morbidity and that blockade of certain mGluR subtypes (mGluR1, mGluR5 and/or mGluR2) may reduce these pathophysiological responses.
AuthorsQ Z Gong, T M Delahunty, R J Hamm, B G Lyeth
JournalBrain research (Brain Res) Vol. 700 Issue 1-2 Pg. 299-302 (Nov 27 1995) ISSN: 0006-8993 [Print] Netherlands
PMID8624726 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Benzoates
  • Excitatory Amino Acid Antagonists
  • Receptors, Metabotropic Glutamate
  • alpha-methyl-4-carboxyphenylglycine
  • Glycine
Topics
  • Analysis of Variance
  • Animals
  • Benzoates (therapeutic use)
  • Blood Pressure (drug effects)
  • Brain Injuries (drug therapy, physiopathology, psychology)
  • Cerebral Ventricles
  • Excitatory Amino Acid Antagonists (therapeutic use)
  • Glycine (analogs & derivatives, therapeutic use)
  • Heart Rate (drug effects)
  • Infusions, Parenteral
  • Male
  • Maze Learning (drug effects)
  • Psychomotor Performance (drug effects)
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Metabotropic Glutamate (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: